Boston Retirement System v. Alexion Pharmaceuticals Inc et al
Case Number:
3:16-cv-02127
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Bernstein Litowitz
- Cohen & Wolf
- Crowell & Moring
- DiCello Levitt
- Diserio Martin
- Hurwitz Sagarin
- Labaton Keller
- Milbank LLP
- Motley Rice
- Orrick Herrington
- Paul Weiss
- Rolnick Kramer
- Scott&Scott
- Wiggin & Dana
Companies
Sectors & Industries:
-
November 16, 2023
Alexion Investors Want $31M Atty Fee In Sales Tactics Deal
Labaton Sucharow LLP and Motley Rice LLC have asked a Connecticut federal judge for roughly $31 million in attorney fees for their work in securing a $125 million settlement for Alexion Pharmaceuticals Inc. shareholders who claimed that the drugmaker caused a double-digit plunge in stock price after its allegedly illegal sales strategy came to light.
-
September 13, 2023
Alexion Inks $125M Deal In Investors' Suit Over Sales Tactics
Alexion shareholders asked a Connecticut federal judge to approve a $125 million settlement to end claims that the drugmaker caused a double-digit plunge in stock price after its allegedly illegal sales strategy came to light, a deal that comes five months after the investors won certification of their class.
-
April 13, 2023
Alexion Investors Win Class Cert. Over Drug Sale Tactics
A Connecticut federal judge on Thursday certified a class of Alexion investors who sued it over a double-digit plunge in its stock price that started when the public began learning of an allegedly illegal strategy to boost sales. The judge also appointed Motley Rice LLC and Labaton Sucharow LLP as co-class counsel.